Gene analysis on SCLC cell lines not only confirmed mTOR pathway as affected by MYCN inhibition but highlighted other genes involved in tumorigenesis as a potential key regulator of BGA002’s mechanism of action. The gene discussed is MYCN; the disease is small cell lung carcinoma.